Compassion vs Control: FDA Investigational‐​Drug Regulation

May 20, 1986 • Policy Analysis No. 72
By Dale H. Gieringer

“The basic problem is, I don’t have as much control over what I can do to get well as I want.”

–AIDS patient[1]

“I think the FDA should recognize its responsibility for the denial of lifesaving technology.”

–Robert Jarvik, developer of the artificial heart[2]

Media Name: pa072.jpg

Download the Policy Analysis

About the Author
Dale H. Gieringer is a writer and policy analyst affiliated with the Decisions and Ethics Center of Stanford University.